Jesse K Fitzpatrick

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Cross Sectional

Cardiovascular Risk Factors

Cardiovascular Disease

Top Venues

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Jeremy Kong, Jonathan G Zaroff, Andrew P Ambrosy, Jesse K Fitzpatrick, Ivy A Ku, Jacob M Mishell, Lak N Kotinkaduwa, Bjorn Redfors, Nirat Beohar, Gorav Ailawadi, JoAnn Lindenfeld, William T Abraham, Michael J Mack, Saibal Kar, D Scott Lim, Brian K Whisenant, Gregg W Stone
Incidence, Predictors, and Outcomes Associated With Worsening Renal Function in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial. Journal of the American Heart Association (2023)
Rishi V Parikh, Alan S Go, Ankeet S Bhatt, Thida C Tan, Amanda R Allen, Kent Y Feng, Steven A Hamilton, Andrew S Tai, Jesse K Fitzpatrick, Keane K Lee, Sirtaz Adatya, Harshith R Avula, Dana R Sax, Xian Shen, Joaquim Cristino, Alexander T Sandhu, Paul A Heidenreich, Andrew P Ambrosy
Developing Clinical Risk Prediction Models for Worsening Heart Failure Events and Death by Left Ventricular Ejection Fraction. Journal of the American Heart Association (2023)
Jesse K Fitzpatrick, Jingrong Yang, Andrew P Ambrosy, Claudia Cabrera, Bergur V Stefansson, Peter J Greasley, Jignesh Patel, Thida C Tan, Alan S Go
Loop and thiazide diuretic use and risk of chronic kidney disease progression: a multicentre observational cohort study. BMJ open 12 (1) (2022)
Andrew P Ambrosy, Jingrong Yang, Sue Hee Sung, Amanda R Allen, Jesse K Fitzpatrick, Jamal S Rana, Jeffrey S Wagener, Sephy Philip, David Abrahamson, Craig Granowitz, Alan S Go
Triglyceride Levels and Residual Risk of Atherosclerotic Cardiovascular Disease Events and Death in Adults Receiving Statin Therapy for Primary or Secondary Prevention: Insights From the KP REACH Study. Journal of the American Heart Association 10 (20) (2021)